Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Translatable Neurophysiological Biomarkers to Enhance Therapeutic Development in Rett Syndrome

NCT05932589 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.

NCT NCT05932589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05932589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Translatable Neurophysiological Biomarkers to Enhance Therapeutic Development in Rett Syndrome
Lead sponsor
Children's Hospital of Philadelphia
Phase
Observational
Overall status
Recruiting
Start date
October 11, 2023
Completion date
March 31, 2029
Enrollment
202 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

rett syndrome, rett syndrome, atypical, rtt